p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma
Barbro Linderholm(Karolinska University Hospital), Roger Henriksson(Umeå University), Kjell Grankvist(Umeå University), Birgitta Lindh(Uppsala University Hospital), Björn Tavelin
International Journal of Cancer
January 20, 2000
Cited by 155
Related Papers
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
|PLoS ONE|2017|668
CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse
|Biochemical Journal|1981|510
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
|Annals of Oncology|2022|461
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
|Annals of Oncology|2017|396
Preanalytical quality improvement: from dream to reality
|Clinical Chemistry and Laboratory Medicine (CCLM)|2011|386